Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Longboard Pharmaceuticals Inc (LBPH)

Longboard Pharmaceuticals Inc (LBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher Motley Fool - Wed Jan 17, 4:51AM CST

You might say that this biotech stock is magnificent.

META : 439.19 (+2.10%)
MSFT : 394.94 (+1.44%)
GOOGL : 163.86 (+0.66%)
AAPL : 169.30 (-0.60%)
TSLA : 179.99 (-1.80%)
AMZN : 179.00 (+2.29%)
NVDA : 830.41 (-3.89%)
GOOG : 165.57 (+0.56%)
LBPH : 21.96 (+3.10%)
Longboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainable Zacks - Mon May 1, 2023

Longboard Pharmaceuticals, Inc. (LBPH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that...

LBPH : 21.96 (+3.10%)
Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why Zacks - Fri Apr 14, 2023

Longboard Pharmaceuticals, Inc. (LBPH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

LBPH : 21.96 (+3.10%)
Longboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference Business Wire - Tue Apr 11, 2023

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Brandi...

LBPH : 21.96 (+3.10%)
Does Longboard Pharmaceuticals, Inc. (LBPH) Have the Potential to Rally 208.22% as Wall Street Analysts Expect? Zacks - Fri Apr 7, 2023

The mean of analysts' price targets for Longboard Pharmaceuticals, Inc. (LBPH) points to a 208.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong...

LBPH : 21.96 (+3.10%)
Wall Street Analysts Predict an 184.81% Upside in Longboard Pharmaceuticals, Inc. (LBPH): Here's What You Should Know Zacks - Tue Mar 7, 2023

The mean of analysts' price targets for Longboard Pharmaceuticals, Inc. (LBPH) points to an 184.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong...

LBPH : 21.96 (+3.10%)
Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives Business Wire - Thu Mar 2, 2023

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update...

LBPH : 21.96 (+3.10%)
Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023 Business Wire - Thu Feb 23, 2023

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it plans...

LBPH : 21.96 (+3.10%)
Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock Business Wire - Fri Feb 10, 2023

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the closing of...

LBPH : 21.96 (+3.10%)
Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock Business Wire - Tue Feb 7, 2023

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of...

LBPH : 21.96 (+3.10%)

Barchart Exclusives

Down 12% from Highs, Should You Buy the Dip in This Dividend Aristocrat? Barchart - Wed May 1, 6:30PM CDT
This prominent paint industry player has been raising dividends for more than four decades. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot